BMP-9 expression in human traumatic heterotopic ossification: a case report by Guillaume Grenier et al.
Grenier et al. Skeletal Muscle 2013, 3:29
http://www.skeletalmusclejournal.com/content/3/1/29CASE REPORT Open AccessBMP-9 expression in human traumatic
heterotopic ossification: a case report
Guillaume Grenier1,2, Élisabeth Leblanc3,4, Nathalie Faucheux1,5, Dominique Lauzier3, Peter Kloen6
and Reggie C Hamdy3,4*Abstract
Background: Heterotopic ossification (HO) is defined as the abnormal formation of mature bone in soft tissue,
notably skeletal muscle. The morbidity of HO in polytraumatized patients impacts the functional outcome, impairs
rehabilitation, and increases costs due to subsequent surgical interventions.
Case presentation: We present the case of a 34-year-old African male who developed severe HO around his right
hip 11 days after a major trauma. Immunohistochemical analyses of resected tissue revealed that several BMPs were
expressed in the HO, including highly osteogenic BMP-9.
Conclusions: To the best of our knowledge, this is the first report of local BMP expression, notably BMP-9, in
traumatic HO, and suggests that BMP-9, possibly through mrSCs, can contribute to HO formation in soft tissues
when a suitable microenvironment is present.
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Heterotopic ossification (HO) involves ectopic bone for-
mation in soft tissues such as muscles and is often associ-
ated with trauma [1]. While the etiology of HO has been
classified as neurogenic, traumatic, and hereditary, the
exact pathophysiology of traumatic HO remains unknown.
However, several critical factors such as progenitor cell
populations, inductive factors, and a permissive environ-
ment may contribute to HO [2,3].
BMPs play a critical role in the osteoblastic commitment
of mesenchymal cells and the induction of osteoblastic ac-
tivity [4,5], and are potential candidates as inductive HO
factors. BMPs are members of the transforming growth
factor-beta (TGF-β) family [6]. More than 20 BMPs have
been described to date, but experimental evidence indicates
that only BMP-2, -6, -7, and -9 can induce osteogenesis,
BMP-9 being one of the most potent osteogenic BMPs
[7,8]. In addition, we recently reported that BMP-9 only
induces HO in damaged muscle in a murine model [9].* Correspondence: rhamdy@shriners.mcgill.ca
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stated.Despite the fact that BMP-9 transcripts are barely detectable
in human skeletal muscle [10], no studies have examined
the expression of BMPs, including BMP-9, in human HO.
The BMP pathway is regulated by a negative feedback
mechanism involving extracellular inhibitors such as nog-
gin, chordin, and gremlin, membrane pseudo-receptors
such as BAMBI, and the intracellular inhibitors Smad-6
and Smad-7 [11,12]. Based on studies by our group and
others on the role of BMPs in normal and pathologic bone
healing [13-17], we hypothesized that the balance between
BMPs and their inhibitors may play a key role in the devel-
opment of traumatic human HO.
In the present report, we describe the case of a patient
with severe lower extremity trauma who developed HO.
We determined the locations of BMPs, extracellular BMP
antagonists, and BMP receptor BMPR1a by immunohisto-
chemical staining. We propose a mechanism to explain
the pathogenesis of trauma-associated HO and provide a
novel perspective on the involvement of members of the
BMP family.
Case presentation
A 34 year-old African male was brought to the emergency
department after jumping from the seventh floor of an
apartment building during a police raid. Physical andLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
Table 1 Primary and secondary antibodies used for the
immunohistochemical staining procedure
Primary antibody Catalog number Type
BMP-2 sc-6895 Goat pAb
BMP-7 sc-34766 Rabbit pAb
BMP-9 sc-130703 Rabbit pAb
Chordin sc-28964 Rabbit pAb
Gremlin sc-28873 Rabbit pAb
Noggin sc-25656 Rabbit pAb
BAMBI sc-100681 Mouse mAb
BMPR1a sc-5676 Goat pAb
Secondary antibody
Biotinylated horse anti-goat IgG BA-9500
Biotinylated goat anti-rabbit IgG BA-1000




Figure 1 Early and late radiological evidence of heterotopic ossificati
scan cut of the acetabular region 11 days post-trauma. Note the denser so
Radiographic AP view of the right hip at 14 days; (B) and three and a half
medially and laterally within the abductor muscles.
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dislocation, and a T-type fracture of the right acetabulum.
On the day of admission (Day 0), an open reduction
and internal fixation (ORIF) of the acetabular fracture
was performed using a standard Kocher-Langenbeck ap-
proach associated with a trochanteric flip [18].
A revision for suboptimal reduction was performed on
Day 10, followed by a second stage ORIF the next day using
an ilioinguinal approach [19]. During the revision surgery, a
mass of heterotopic bone was resected and sent for analysis.
The patient did not receive NSAIDs or radiotherapy pre-
operatively. Clinical and radiological evaluations were per-
formed for three and a half months postoperatively.
Methods
Tissue specimen
The tissue specimen harvested during the second sur-
gery (Day 11) was processed for immunohistochemical
and histological analyses.C
32.4 kVA (81 kVx0.4A; mAs=16)
on around the right hip. (A) Axial computerized tomography (CT)
ft tissues (encircled) surrounding the right fractured acetabulum.
months; (C) post-trauma. Note the progression of calcified soft tissues
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The sample was fixed in buffered formalin overnight,
decalcified in 10% EDTA (pH 7.2) for three weeks, em-
bedded in paraffin, and sectioned using a Leica RM
2255 microtome (Leica Microsystems, Richmond Hill,
ON, Canada). Following deparaffinization and hydra-
tion, the tissue sections were stained with Goldner’s
trichrome to visualize nuclei (blue-gray), cartilage (red-
purple), osteoid (orange-red), and mineralized bone
(green).
The immunohistochemistry was performed as described
previously [13-15]. Commercially available goat and rabbit
pAbs and a mouse mAb (1:100 in 1% goat or 1% horse
serum) were used to detect BMP-2, BMP-7, BMP-9, nog-
gin, gremlin, BMPR1a, and BAMBI (Santa Cruz Biotech-
nology Inc., Santa Cruz, CA, USA). A list of the antibodies
is given in Table 1.Grading of the immunostained sections
Immunohistochemical staining of cellular and extracel-
lular proteins has been used in mandibular [20], long
bone distraction osteogenesis [21-24], and bone healing
[13-15] studies. We employed this technique to semi-
quantitatively evaluate our results based on the percentage
of positively stained cells using the following grading
scheme: +, 25% of the cells stained positively for the pro-
tein of interest; ++, 25 to 50% of the cells stained posi-
tively; +++, 50 to 75% of the cells stained positively; ++++,
more than 75% of the cells stained positively; −, no cells
stained positively.Figure 2 Resected heterotopic ossification (HO) tissue with endochon
with Goldner’s trichrome. AD, adipocyte; B, bone; BM, bone marrow; CH, chResults
Radiological and clinical follow-up
Computerized tomography (CT) imaging prior to the sec-
ond surgery (Day 11) revealed the presence of dense ec-
topic tissue in the musculature (Figure 1A). A post-ORIF
radiological examination (Day 14) revealed adequate re-
duction/fixation as well as the presence of dense tissue in
the abductor muscles (Figure 1B). Three and a half months
later, a repeat antero-posterior (AP) radiograph of the pel-
vis revealed a healed fracture and a Brooker radiologic
stage III-IV HO (Figure 1C) [25]. While follow-up with this
patient was limited, clinical notes indicated that he had a
stiff hip gait.
Macroscopic and microscopic tissue organization
The resected tissue had a macroscopic rubbery texture on
the day of the revision surgery (Day 11). A histological
examination showed that the tissue was composed mainly
of mature bone and cartilage (Figure 2). Adipocytes orga-
nized in a bone marrow-like structure in the ectopic bone
were also observed. The structure was well vascularized,
as previously reported [9,26]. We also observed muscle
fiber remnants intertwined with the tissue.
Expression of BMPs, BMP receptors and their antagonists
Chondrocytes stained fairly strongly for BMP-2 (Figure 3).
Interestingly, while BMP-9 was expressed in various cell
types, the most intense staining was observed in osteo-
blasts followed by endothelial cells (Figure 3). The receptor
antagonist BAMBI was mainly expressed in osteoblasts
while BMPR1a was mainly expressed in chondrocytes.dral ossification. Micrograph of a section of resected tissue stained
ondrocyte; MF, myofiber; OB, osteoblast. Scale bar = 100 μm.
Table 2 Immunolocalization of BMP receptors, agonists,
and antagonists
Antibody OB CH FB MC
BMP-2 + ++++ - ++
BMP-7 - + - +++
BMP-9 ++ + - +
BMPR1a - ++++ - -
Chordin - ++ + ++++
Gremlin - ++++ + +++
Noggin - ++++ + ++
BAMBI ++ - - -
CH: chondrocytes; FB: fibroblasts; MC: mesenchymal cells; OB: osteoblasts.
Figure 3 Immunostaining of resected heterotopic ossification (HO) tissue. Micrographs of resected tissue immunostained for various
proteins in the BMP pathway. The control shows background staining. BV, blood vessel; CH, chondrocyte; EC, endothelial cell. MC, mesenchymal
cell; OB, osteoblast.
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of BMP-2 and BMP-7, were mainly observed in chondro-
cytes and mesenchymal cells. See Table 2 for a summary of
the immunostaining results.
Discussion
In the present case report, we describe for the first time
the expression patterns of several BMPs as well as BMP re-
ceptors and their antagonists in traumatic HO. We found
that BMP expression patterns were cell type-dependent,
with chondrocytes expressing the highest levels of BMP-2,
mesenchymal cells the highest levels of BMP-7, and osteo-
blasts and endothelial cells the highest levels of BMP-9.
This is the first time that BMP-9 has been shown to be
expressed in human ectopic bone. This is an important
finding since it has been previously reported that BMP-9 is
the most osteogenic BMP both in vitro and in vivo [7,8].
Unlike BMP-2, which can induce HO in undamaged skel-
etal muscle, BMP-9 induces HO only in damaged muscle
[9]. While BMP-2 and BMP-9 share the same pathway,
they do not appear to be functionally equivalent in terms
of inducing heterotopic bone in skeletal muscle. Two main
factors seem to be responsible for this difference and makethe involvement of BMP-9 in HO more plausible. The
microenvironment of cells in damaged muscle is more
permissive to the development of HO [9,27]. Since BMP-9
is involved in angiogenesis [28] and participates in endo-
thelial cell proliferation, severe muscle trauma may pro-
mote higher local expression of BMP-9 and, as such, HO.
In addition, despite the fact that BMP inhibitors were
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Figure 4 Diagram illustrating that BMP-9 may play a pivotal role in heterotopic ossification (HO) because of the more permissive
environment of damaged muscle and the inability of BMP inhibitors in the tissue to alter the osteogenic program of multipotent
progenitor cells.
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tagonist of BMP-2 and BMP-7, cannot inhibit BMP-9
[29,30] (Figure 4).
The difference in BMP expression in healing frac-
tures and in HO might also be explained by the nature
of the cells involved. A number of studies using ani-
mal models [9,31] and human cells [32] have shown
that muscle resident stromal cells (mrSCs) with high
osteogenic potential contribute to HO. This finding
has important clinical implications since mrSCs may
be involved in fracture repair [33-35]. More import-
antly, non-unions are more likely to be associated with
bones with minimal soft tissue coverage such as the tibia,
and it has been proposed that non-unions could occur
due to the lack of enveloping muscle tissue [36]. The
present case report underlines the importance of concen-
trating future studies on identifying the true role of multi-
potent mrSCs and the pathway leading to their osteogenic
commitment.Conclusions
We showed that BMPs are expressed in traumatic HO
and that BMP-9 in particular may play a pivotal role in
HO because of the more permissive environment of
damaged muscle and the inability of BMP inhibitors in
the microenvironment to alter the osteogenic program
of multipotent progenitor cells. We propose that osteo-
genic multipotent progenitor cells, including mrSCs, and
their signaling pathways should be investigated further
with a view to developing prophylactic measures to pre-
vent traumatic HO.Consent
Informed consent was obtained from the patient for the
publication of this case report and any accompanying
images.
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